Ishita Drugs & Industries share news, announcements and annual reports
BSE: 524400Pharmaceuticals & BiotechnologySmall Cap
Ishita Drugs & Industries Ltd. · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Feb 1994
Last close ₹73.80down ₹0.80 (1.07%)
Share price at the BSE close on 29 Oct 2026. Previous close ₹74.60.
29 Oct: open ₹70.15, high ₹74.59, low ₹68.95
52-week range of traded prices to 29 Oct 2026
₹66.00Low, 13 Jan 2026₹90.85High, 29 Dec 2025
- Next results date: the board meets on 3 Nov 2026 to consider: quarterly results. Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹22 Cr4,064th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 31.24
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.91
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 6.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 5.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.01
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 4,584
Ishita Drugs & Industries shareholder meetings
65 filed, newest first. Page 2 of 2.
Aug 2016
Oct 2015
Aug 2015
14 Aug · Meeting
Register of Members & Share Transfer Books of the Company will remain closed from September 24, 2015 to September 30, 2015 (both ....
Oct 2014
Aug 2014
21 Aug · Meeting
Register of Members & Share Transfer Books of the Company will remain closed from September 24, 2014 to September 30, 2014 (both ....
Oct 2013
Aug 2013
19 Aug · Meeting
Register of Members & Share Transfer Books of the Company will remain closed from September 23, 2013 to September 30, 2013 (both ....
Sep 2011
3 Sep · Meeting
Register of Members & Share Transfer Books of the Company will remain closed from September 23, 2011 to September 30, 2011 (both ....
Oct 2010
Aug 2010
25 Aug · Meeting
Register of Members & Share Transfer Books of the Company will remain closed from September 25, 2010 to September 30, 2010 (both ....
Mar 2010
8 Mar · Meeting
Members at the Extra Ordinary General Meeting (EGM) of the Company held on March 04, 2010, have accorded to the commencement of new ....
Jan 2010